Indications for and efficacy of splenectomy for haematological disorders

British Journal of Surgery

Volumn 100, Issue 6, 2013, Pages 794-800

  Bickenbach, K A ^a   Gonen, M ^a   Labow, D M ^b   Strong, V ^a   Heaney, M L ^a   Zelenetz, A D ^a   Coit, D G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONVERSION TO OPEN SURGERY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INFANT; LAPAROTOMY; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; OPERATION DURATION; OPERATIVE BLOOD LOSS; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; RISK FACTOR; SPLENECTOMY; STATISTICS; THROMBOCYTE COUNT; TREATMENT OUTCOME; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD LOSS, SURGICAL; CHILD; CHILD, PRESCHOOL; CONVERSION TO OPEN SURGERY; FEMALE; HEMATOLOGIC DISEASES; HEMOGLOBINS; HUMANS; INFANT; LAPAROTOMY; MALE; MIDDLE AGED; OPERATIVE TIME; PLATELET COUNT; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SPLENECTOMY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875847688     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9067     Document Type: Article

References (18)

1. Horowitz J, Smith JL, Weber TK, Rodriguez-Bigas MA, Petrelli NJ,. Postoperative complications after splenectomy for hematologic malignancies. Ann Surg 1996; 223: 290-296.
2. MacRae HM, Yakimets WW, Reynolds T,. Perioperative complications of splenectomy for hematologic disease. Can J Surg 1992; 35: 432-436.
3. Nelson EW, Mone MC,. Splenectomy in high-risk patients with splenomegaly. Am J Surg 1999; 178: 581-586.
4. Arnoletti JP, Karam J, Brodsky J,. Early postoperative complications of splenectomy for hematologic disease. Am J Clin Oncol 1999; 22: 114-118.
5. Karnofsky DA, Burchenal JH,. The clinical evaluation of chemotherapeutic agents in cancer. In Evaluation of Chemotherapeutic Agents, MacLeod CM, (ed.). Columbia University Press: New York, 1949; 191-205.
6. Grobmyer SR, Pieracci FM, Allen PJ, Brennan MF, Jaques DP,. Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system. J Am Coll Surg 2007; 204: 356-364.
7. Schwartz SI,. Role of splenectomy in hematologic disorders. World J Surg 1996; 20: 1156-1159.
8. Targarona EM, Espert JJ, Cerdán G, Balagué C, Piulachs J, Sugrañes G, et al. Effect of spleen size on splenectomy outcome. A comparison of open and laparoscopic surgery. Surg Endosc 1999; 13: 559-562.
9. Rosen M, Brody F, Walsh RM, Tarnoff M, Malm J, Ponsky J,. Outcome of laparoscopic splenectomy based on hematologic indication. Surg Endosc 2002; 16: 272-279.
10. Uranues S, Alimoglu O,. Laparoscopic surgery of the spleen. Surg Clin North Am 2005; 85: 75-90, ix.
11. Musser G, Lazar G, Hocking W, Busuttil RW,. Splenectomy for hematologic disease. The UCLA experience with 306 patients. Ann Surg 1984; 200: 40-45.
12. Malmaeus J, Akre T, Adami HO, Hagberg H,. Early postoperative course following elective splenectomy in haematological diseases: a high complication rate in patients with myeloproliferative disorders. Br J Surg 1986; 73: 720-703.
13. Wilhelm MC, Jones RE, McGehee R, Mitchener JS, Sandusky WR, Hess CE,. Splenectomy in hematologic disorders. The ever-changing indications. Ann Surg 1988; 207: 581-589.
14. Goldstone J., Splenectomy for massive splenomegaly. Am J Surg 1978; 135: 385-388.
15. Walsh RM, Brody F, Brown N,. Laparoscopic splenectomy for lymphoproliferative disease. Surg Endosc 2004; 18: 272-275.
16. McAneny D, LaMorte WW, Scott TE, Weintraub LR, Beazley RM,. Is splenectomy more dangerous for massive spleens? Am J Surg 1998; 175: 102-107.
17. Wobbes T, van der Sluis RF, Lubbers EJ,. Removal of the massive spleen: a surgical risk? Am J Surg 1984; 147: 800-802.
18. Poulin EC, Mamazza J,. Laparoscopic splenectomy: lessons from the learning curve. Can J Surg 1998; 41: 28-36.